98 related articles for article (PubMed ID: 3056274)
1. [Role of autologous bone marrow transplantation in cancer chemotherapy].
Tajima T; Tokuda Y; Kubota M; Ohta M; Yokoyama S; Mitomi T; Nakamura Y; Watanabe K; Murakami M; Shinozuka T
Gan To Kagaku Ryoho; 1988 Nov; 15(11):3018-24. PubMed ID: 3056274
[TBL] [Abstract][Full Text] [Related]
2. [Autologous bone marrow transplantation as a measure against myelosuppression in cancer chemotherapy].
Tajima T; Tokuda Y; Ohta M; Okumura A; Norihisa Y; Kubota M; Noto T; Fujimoto T; Nakasaki H; Yokoyama S
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1085-93. PubMed ID: 2658812
[TBL] [Abstract][Full Text] [Related]
3. High-dose chemotherapy, autologous bone marrow or stem cell transplantation and post-transplant consolidation chemotherapy in patients with advanced breast cancer.
Tallman MS; Rademaker AW; Jahnke L; Brown SG; Bauman A; Mangan C; Kelly C; Rubin H; Kies MS; Shaw J; Kiel K; Gordon LI; Gradishar WJ; Winter JN
Bone Marrow Transplant; 1997 Nov; 20(9):721-9. PubMed ID: 9384473
[TBL] [Abstract][Full Text] [Related]
4. [Combination of high-dose chemotherapy with autologous hematopoietic stem cell transplantation for recurrent and high-risk breast cancer: a pilot study].
Shi Y; Pan F; Han X
Zhonghua Yi Xue Za Zhi; 1999 Dec; 79(12):890-3. PubMed ID: 11715500
[TBL] [Abstract][Full Text] [Related]
5. [Effect of high dose etoposide, adriamycin, cisplatin (EAP) therapy with autologous bone marrow transplantation in gastric cancer].
Suzuki T; Ochiai T; Ozaki M; Asano T; Koide Y; Gunji Y; Shu S; Hori S; Nabeya Y; Isono K
Gan To Kagaku Ryoho; 1990 May; 17(5):1069-72. PubMed ID: 2334173
[TBL] [Abstract][Full Text] [Related]
6. [Autologous bone marrow transplantation--its role in the chemotherapy of solid tumor].
Tajima T; Tokuda H; Ota M; Okumura T; Norihisa Y; Kubota M; Yokoyama S; Mitomi T; Kakio S; Tsuji K
Gan No Rinsho; 1989 May; Spec No():303-11. PubMed ID: 2601018
[No Abstract] [Full Text] [Related]
7. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
[TBL] [Abstract][Full Text] [Related]
8. Phase I trial of high-dose melphalan, high-dose etoposide and autologous bone marrow re-infusion in solid tumors: an Eastern Cooperative Oncology Group (ECOG) study.
Lazarus HM; Gray R; Ciobanu N; Winter J; Weiner RS
Bone Marrow Transplant; 1994 Sep; 14(3):443-8. PubMed ID: 7994270
[TBL] [Abstract][Full Text] [Related]
9. Randomized, comparative study of high-dose (with autologous bone marrow support) versus low-dose cyclophosphamide, cisplatin, and carmustine as consolidation to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for patients with operable stage II or III breast cancer involving 10 or more axillary lymph nodes (CALGB Protocol 9082). Cancer and Leukemia Group B.
Hurd DD; Peters WP
J Natl Cancer Inst Monogr; 1995; (19):41-4. PubMed ID: 7577204
[TBL] [Abstract][Full Text] [Related]
10. Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066.
Peppercorn J; Herndon J; Kornblith AB; Peters W; Ahles T; Vredenburgh J; Schwartz G; Shpall E; Hurd DD; Holland J; Winer E
Cancer; 2005 Oct; 104(8):1580-9. PubMed ID: 16118805
[TBL] [Abstract][Full Text] [Related]
11. High-dose chemotherapy with autologous stem cell rescue in women with metastatic breast cancer with involved bone marrow: a role for peripheral blood progenitor transplant.
Myers SE; Mick R; Williams SF
Bone Marrow Transplant; 1994 Apr; 13(4):449-54. PubMed ID: 8019470
[TBL] [Abstract][Full Text] [Related]
12. High-dose combination alkylating agent preparative regimen with autologous bone marrow support: the Dana-Farber Cancer Institute/Beth Israel Hospital experience.
Antman K; Eder JP; Elias A; Shea T; Peters WP; Andersen J; Schryber S; Henner WD; Finberg R; Wilmore D
Cancer Treat Rep; 1987 Feb; 71(2):119-25. PubMed ID: 3542208
[TBL] [Abstract][Full Text] [Related]
13. [Autologous bone marrow transplantation in osteosarcoma].
Ohira M; Takayama J; Hanada M; Adachi N; Fukuma H
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1438-43. PubMed ID: 3296955
[TBL] [Abstract][Full Text] [Related]
14. High-dose cyclophosphamide, etoposide and carboplatin with autologous bone marrow support for metastatic breast cancer: long-term results.
Baker WJ; Vukelja SJ; Burrell LM; Lee N; Perry JJ
Bone Marrow Transplant; 1998 Apr; 21(8):775-8. PubMed ID: 9603400
[TBL] [Abstract][Full Text] [Related]
15. Tandem high-dose chemotherapy supported by hematopoietic progenitor cells yields prolonged survival in stage IV breast cancer.
Bitran JD; Samuels B; Klein L; Hanauer S; Johnson L; Martinec J; Harris E; Kempler J; White W
Bone Marrow Transplant; 1996 Feb; 17(2):157-62. PubMed ID: 8640160
[TBL] [Abstract][Full Text] [Related]
16. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
17. Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumors.
Motzer RJ; Gulati SC; Tong WP; Menendez-Botet C; Lyn P; Mazumdar M; Vlamis V; Lin S; Bosl GJ
Cancer Res; 1993 Aug; 53(16):3730-5. PubMed ID: 8393380
[TBL] [Abstract][Full Text] [Related]
18. Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer.
Gisselbrecht C; Extra JM; Lotz JP; Devaux Y; Janvier M; Peny AM; Guillevin L; Bremond D; Delain M; Herbrecht R; Lepage E; Maraninchi D
Bone Marrow Transplant; 1996 Nov; 18(5):857-63. PubMed ID: 8932837
[TBL] [Abstract][Full Text] [Related]
19. [High-dose chemotherapy with autologous bone marrow transplantation as treatment for relapsing testicular cancer].
Suzuki K; Ohishi M; Sobajima T; Murase T; Ito H; Akatsuka Y
Hinyokika Kiyo; 1991 Apr; 37(4):403-6. PubMed ID: 1892001
[TBL] [Abstract][Full Text] [Related]
20. High-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy: analysis by age.
Antman K; Ayash L; Elias A; Wheeler C; Schwartz G; Mazanet R; Tepler I; Schnipper LE; Frei E
J Natl Cancer Inst Monogr; 1994; (16):91-4. PubMed ID: 7528031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
